KalVista Pharmaceuticals, Inc.KALVNASDAQ
LOADING
|||
Switch Symbol:
Net Income Contraction
Trending lower, below historical average, strong compound growth.
Left:
||||
Total earnings after all expenses, taxes, and interest
Latest
$-183.44M
↓ 192% below average
Average (9y)
$-62.74M
Historical baseline
Range
High:$-11.44M
Low:$-183.44M
CAGR
+36.1%
Consistent expansion
| Period | Value | Change |
|---|---|---|
| 2025 | $-183.44M | -44.9% |
| 2024 | $-126.64M | -36.3% |
| 2023 | $-92.91M | -12.8% |
| 2022 | $-82.34M | -78.1% |
| 2021 | $-46.24M | -58.8% |
| 2020 | $-29.12M | -39.9% |
| 2019 | $-20.82M | -31.7% |
| 2018 | $-15.80M | +15.0% |
| 2017 | $-18.60M | -62.7% |
| 2016 | $-11.44M | - |